The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status
Year: 2019
Type: article
Study design: Observational Study
Source: Annals of Surgery
Authors: Georgios Antonios Margonis, Neda Amini, Stefan Buettner, Yuhree Kim, Jaeyun Wang, Nikolaos Andreatos, Doris Wagner, Kazunari Sasaki, Andrea Beer, Carsten Kamphues, Daisuke Morioka, Inger Marie Løes, Katsunori Imai, Jin He, Timothy M. Pawlik, Klaus Kaczirek, George Poultsides, Per Eystein Lønning, Richard Burkhart, Itaru Endo, Hideo Baba, Hans Joerg Mischinger, Federico N. Aucejo, Martin E. Kreis, Christopher L. Wolfgang, Matthew J. Weiss
Institutions: Johns Hopkins University, Johns Hopkins Medicine, Harvard University, Massachusetts General Hospital, Harvard Pilgrim Health Care, Medical University of Graz, Cleveland Clinic, Medical University of Vienna, Stiftung Charité, Charité - Universitätsmedizin Berlin, Yokohama City University, Haukeland University Hospital, University of Bergen, Kumamoto University, The Ohio State University Wexner Medical Center, The Ohio State University, Stanford Medicine, Stanford University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2966183449